The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Crohn’s Disease Drug-Global Market Insights and Sales Trends 2024

Crohn’s Disease Drug-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1847687

No of Pages : 92

Ask Your Query
Synopsis
The global Crohn’s Disease Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Crohn’s Disease Drug in various end use industries. The expanding demands from the Achieving Remission (The Absence Of Symptoms), Maintaining Remission (Prevention Of Flare-Ups) and Pediatric Crohn'S Disease,, are propelling Crohn’s Disease Drug market. Aminosalicylates (5-ASA), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Corticosteroids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Crohn’s Disease Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Crohn’s Disease Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Crohn’s Disease Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Crohn’s Disease Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Crohn’s Disease Drug covered in this report include AbbVie, Janssen Biotech, Amgen, Tillotts Pharma and Takeda Pharmaceuticals, etc.
The global Crohn’s Disease Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Janssen Biotech
Amgen
Tillotts Pharma
Takeda Pharmaceuticals
Global Crohn’s Disease Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Crohn’s Disease Drug market, Segment by Type:
Aminosalicylates (5-ASA)
Corticosteroids
Immunomodulators
Antibiotics
Global Crohn’s Disease Drug market, by Application
Achieving Remission (The Absence Of Symptoms)
Maintaining Remission (Prevention Of Flare-Ups)
Pediatric Crohn'S Disease
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Crohn’s Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Crohn’s Disease Drug Market Overview
1.1 Crohn’s Disease Drug Product Overview
1.2 Crohn’s Disease Drug Market Segment by Type
1.2.1 Aminosalicylates (5-ASA)
1.2.2 Corticosteroids
1.2.3 Immunomodulators
1.2.4 Antibiotics
1.3 Global Crohn’s Disease Drug Market Size by Type
1.3.1 Global Crohn’s Disease Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Crohn’s Disease Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Crohn’s Disease Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Crohn’s Disease Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Crohn’s Disease Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Crohn’s Disease Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Crohn’s Disease Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Crohn’s Disease Drug Sales Breakdown by Type (2018-2023)
2 Global Crohn’s Disease Drug Market Competition by Company
2.1 Global Top Players by Crohn’s Disease Drug Sales (2018-2023)
2.2 Global Top Players by Crohn’s Disease Drug Revenue (2018-2023)
2.3 Global Top Players by Crohn’s Disease Drug Price (2018-2023)
2.4 Global Top Manufacturers Crohn’s Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Crohn’s Disease Drug Market Competitive Situation and Trends
2.5.1 Crohn’s Disease Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Crohn’s Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Crohn’s Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Crohn’s Disease Drug Market
2.8 Key Manufacturers Crohn’s Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Crohn’s Disease Drug Status and Outlook by Region
3.1 Global Crohn’s Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Crohn’s Disease Drug Historic Market Size by Region
3.2.1 Global Crohn’s Disease Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Crohn’s Disease Drug Sales in Value by Region (2018-2023)
3.2.3 Global Crohn’s Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Crohn’s Disease Drug Forecasted Market Size by Region
3.3.1 Global Crohn’s Disease Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Crohn’s Disease Drug Sales in Value by Region (2024-2029)
3.3.3 Global Crohn’s Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Crohn’s Disease Drug by Application
4.1 Crohn’s Disease Drug Market Segment by Application
4.1.1 Achieving Remission (The Absence Of Symptoms)
4.1.2 Maintaining Remission (Prevention Of Flare-Ups)
4.1.3 Pediatric Crohn'S Disease
4.2 Global Crohn’s Disease Drug Market Size by Application
4.2.1 Global Crohn’s Disease Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Crohn’s Disease Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Crohn’s Disease Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Crohn’s Disease Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Crohn’s Disease Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Crohn’s Disease Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Crohn’s Disease Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Crohn’s Disease Drug Sales Breakdown by Application (2018-2023)
5 North America Crohn’s Disease Drug by Country
5.1 North America Crohn’s Disease Drug Historic Market Size by Country
5.1.1 North America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Crohn’s Disease Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Crohn’s Disease Drug Sales in Value by Country (2018-2023)
5.2 North America Crohn’s Disease Drug Forecasted Market Size by Country
5.2.1 North America Crohn’s Disease Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Crohn’s Disease Drug Sales in Value by Country (2024-2029)
6 Europe Crohn’s Disease Drug by Country
6.1 Europe Crohn’s Disease Drug Historic Market Size by Country
6.1.1 Europe Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Crohn’s Disease Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Crohn’s Disease Drug Sales in Value by Country (2018-2023)
6.2 Europe Crohn’s Disease Drug Forecasted Market Size by Country
6.2.1 Europe Crohn’s Disease Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Crohn’s Disease Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Crohn’s Disease Drug by Region
7.1 Asia-Pacific Crohn’s Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Crohn’s Disease Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Crohn’s Disease Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Crohn’s Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Crohn’s Disease Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Crohn’s Disease Drug Sales in Value by Region (2024-2029)
8 Latin America Crohn’s Disease Drug by Country
8.1 Latin America Crohn’s Disease Drug Historic Market Size by Country
8.1.1 Latin America Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Crohn’s Disease Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Crohn’s Disease Drug Sales in Value by Country (2018-2023)
8.2 Latin America Crohn’s Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Crohn’s Disease Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Crohn’s Disease Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Crohn’s Disease Drug by Country
9.1 Middle East and Africa Crohn’s Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Crohn’s Disease Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Crohn’s Disease Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Crohn’s Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Crohn’s Disease Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Crohn’s Disease Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Crohn’s Disease Drug Products Offered
10.1.5 AbbVie Recent Development
10.2 Janssen Biotech
10.2.1 Janssen Biotech Company Information
10.2.2 Janssen Biotech Introduction and Business Overview
10.2.3 Janssen Biotech Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Janssen Biotech Crohn’s Disease Drug Products Offered
10.2.5 Janssen Biotech Recent Development
10.3 Amgen
10.3.1 Amgen Company Information
10.3.2 Amgen Introduction and Business Overview
10.3.3 Amgen Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Amgen Crohn’s Disease Drug Products Offered
10.3.5 Amgen Recent Development
10.4 Tillotts Pharma
10.4.1 Tillotts Pharma Company Information
10.4.2 Tillotts Pharma Introduction and Business Overview
10.4.3 Tillotts Pharma Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Tillotts Pharma Crohn’s Disease Drug Products Offered
10.4.5 Tillotts Pharma Recent Development
10.5 Takeda Pharmaceuticals
10.5.1 Takeda Pharmaceuticals Company Information
10.5.2 Takeda Pharmaceuticals Introduction and Business Overview
10.5.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Takeda Pharmaceuticals Crohn’s Disease Drug Products Offered
10.5.5 Takeda Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Crohn’s Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Crohn’s Disease Drug Industrial Chain Analysis
11.4 Crohn’s Disease Drug Market Dynamics
11.4.1 Crohn’s Disease Drug Industry Trends
11.4.2 Crohn’s Disease Drug Market Drivers
11.4.3 Crohn’s Disease Drug Market Challenges
11.4.4 Crohn’s Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Crohn’s Disease Drug Distributors
12.3 Crohn’s Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock